IIT Bombay’s Society for Innovation and Entrepreneurship
IIT Bombay’s Society for Innovation and Entrepreneurship:
Pioneering India’s Deep-Tech Startup Ecosystem
The Society for
Innovation and Entrepreneurship (SINE) at IIT Bombay, established in 2004, is a
cornerstone of India’s startup ecosystem, nurturing over 200 tech startups
valued at $1 billion and creating 5,500 jobs by 2025. With successes like
ImmunoACT, IdeaForge, and Detect Technologies, SINE has filed 200+ intellectual
properties (IPs) and attracted $736.91 million in funding. Its “Start to Scale”
model supports deep-tech ventures in biotech, aerospace, and sustainability.
Looking ahead, SINE aims to expand its portfolio, strengthen global
partnerships, and scale med-tech and climate-tech startups. Venture capitalists
(VCs) are enthusiastic, though hardware startups face funding challenges.
Compared to incubators like IITMIC, SIIC, NSRCEL, T-Hub, and C-CAMP, SINE
excels in global outreach and industry ties. This note explores SINE’s
achievements, investor dynamics, case studies, comparisons, and future outlook.
SINE’s Role in Shaping India’s Startup Landscape
If you’re hunting for a hub where deep-tech dreams turn into
reality, IIT Bombay’s Society for Innovation and Entrepreneurship (SINE) is
your spot. Since kicking off in 2004, SINE has been a trailblazer, nurturing
over 200 startups worth $1 billion and creating 5,500 jobs by 2025. From
cancer-fighting biotech to space-tech ventures, SINE’s “Start to Scale” model
has birthed game-changers like ImmunoACT and IdeaForge. “SINE is a pioneer in
India’s incubation ecosystem,” says CEO Shaji Varghese, and he’s got a point.
But how does SINE stack up against giants like IIT Madras Incubation Cell
(IITMIC) or T-Hub? Who’s pouring money into these ventures, and what’s next?
Let’s dive into SINE’s achievements, the VC buzz, case studies, and its bold
plans, with insights from experts and investors.
Achievements of SINE: A 21-Year Legacy
SINE’s journey began in 2004, building on IIT Bombay’s
entrepreneurial spirit, which was already sparking with the Entrepreneurship
Cell (E-Cell) in 1998. Here’s what SINE has accomplished:
Portfolio Strength: SINE has incubated over 200
startups, with 55 active companies valued at $1 billion, creating 5,500 jobs.
“Our startups drive economic growth,” says Poyni Bhatt, former SINE CEO.
- Intellectual
Property: Over 200 IPs, including 41 from IIT Bombay, have been filed.
“IP is our core strength,” says Varghese.
- Notable
Successes:
- ImmunoACT:
Launched NexCAR19, India’s first CAR-T cell therapy for cancer, dedicated
by President Droupadi Murmu in 2025. “This is a landmark for Indian
biotech,” says Rahul Purwar, ImmunoACT founder.
- IdeaForge:
A drone tech leader, serving defense and civilian sectors. “IdeaForge
showcases SINE’s deep-tech prowess,” says investor Vinod Keni.
- Detect
Technologies: Specializes in AI-based industrial monitoring. “Their
tech is transformative,” says Qualcomm’s Rahul Patel.
- Industry
Collaboration: SINE partners with DST, Intel, Qualcomm, and Canara
Bank, offering financial support through schemes like PRAYAS. “Our
industry ties are unmatched,” says Bhatt.
- Global
Recognition: Selected as a Centre of Excellence by DST and an
implementation partner for nationwide prototyping programs. “SINE’s model
is a playbook for India,” says Varghese.
- Social
Impact: Startups like Voltrez Tech (safe lithium-ion batteries) and
UrjanovaC (CO2 capture) address global challenges. “SINE’s startups solve
real problems,” says Prof. Vikram Vishal, UrjanovaC founder.
- Events
and Workshops: SINE hosts workshops like “IPR: Issues &
Considerations” and collaborates with E-Cell for E-Summit, Asia’s largest
business conclave. “E-Summit is a startup magnet,” says E-Cell’s Omkar
Karnani.
Case Study 1: ImmunoACT
ImmunoACT, incubated by SINE, developed NexCAR19, India’s
first CAR-T cell therapy for blood cancer, launched in 2025. Led by Dr. Rahul
Purwar, it addresses India’s rising cancer burden (29.8 million cases by 2025).
Backed by Laurus Labs, it’s a game-changer. “ImmunoACT makes advanced therapy
affordable,” says Purwar. SINE’s mentorship and DST funding were critical.
“SINE’s support took us from lab to market,” says co-founder Atharva Karulkar.
Case Study 2: IdeaForge
IdeaForge, a drone tech pioneer, has scaled to serve India’s
defense and civilian sectors. Founded by IIT Bombay alumni, it raised $20
million from investors like Florintree. “IdeaForge’s drones are world-class,”
says Florintree’s Mathew Cyriac. SINE’s prototyping support and industry
connects helped it soar. “SINE gave us the runway to scale,” says founder Ankit
Mehta.
Case Study 3: UrjanovaC
UrjanovaC, led by Prof. Vikram Vishal, develops CO2 capture
technology for net-zero emissions. With India as the third-largest greenhouse
gas emitter, its scalable solutions are vital. “UrjanovaC aligns with India’s
2070 net-zero goal,” says Vishal. SINE’s BioNest incubator provided seed
funding, but scaling remains capital-intensive. “Hardware needs patient
capital,” says Vishal.
Case Study 4: Voltrez Tech
Voltrez Tech tackles lithium-ion battery safety by reducing
dendrite formation. A large pilot is underway, promising safer, longer-lasting
batteries. “This could revolutionize energy storage,” says Varghese. SINE’s
technical support and industry partnerships have been key. “SINE’s ecosystem is
unmatched,” says founder Shreyas Patankar.
Outlook for the Next Five Years
SINE’s vision is to scale its impact and go global. “We’re
building a deep-tech powerhouse,” says Varghese. Here’s the plan:
- Portfolio
Expansion: Aim to incubate 100 startups annually, focusing on biotech,
climate-tech, and AI. “We’ll double our impact,” says Bhatt.
- Global
Partnerships: Strengthen ties with international organizations and
expand BRICS collaborations. “Our Russia partnerships are just the start,”
says Patel.
- Med-Tech
Focus: Scale BioNest to support more health-tech startups like
ImmunoACT. “Biotech is India’s future,” says Purwar.
- Climate-Tech
Push: Back startups like UrjanovaC to meet India’s 2070 net-zero goal.
“Sustainability is non-negotiable,” says Vishal.
- Mentorship
and Funding: Enhance VC-in-house programs and leverage Canara Bank’s
Startup Scheme. “Funding access is critical,” says Canara Bank’s Ashok
Chandra.
- IP
Growth: Target 300 IPs by 2028. “IP drives valuation,” says Santosh
Gharpure, SINE mentor.
Venture Capital and Investor Dynamics
SINE startups have raised $736.91 million, with $3.92
million in seed funding from SINE. “Our startups are VC magnets,” says
Varghese. Key investors include:
- Alumni
Investors:
- Nandan
Nilekani (Infosys): Supports SINE’s ecosystem. “SINE’s alumni network
is its strength,” he says.
- Bhavish
Aggarwal (Ola): Backs early-stage ventures. “SINE shaped Ola’s
journey,” he says.
- Bharat
Desai and Neerja Sethi: Funded the Desai Sethi School of
Entrepreneurship. “SINE fosters innovation,” says Desai.
- Corporate
VCs:
- Laurus
Labs: Backed ImmunoACT. “Their biotech innovation is unmatched,” says
CEO Satyanarayana Chava.
- Qualcomm:
Supports Detect Technologies. “SINE’s startups are industry-ready,” says
Patel.
- Intel:
Funds tech ventures. “SINE’s ecosystem is robust,” says Nivruti Rai.
- Canara
Bank: Partners via the Startup Scheme. “We empower startups,” says
Chandra.
- Angel
and VC Firms:
- Florintree:
Invested in IdeaForge. “Drones are the future,” says Cyriac.
- Blume
Ventures: Backs AI startups. “SINE’s tech pipeline is strong,” says
Karthik Reddy.
- 3one4
Capital: Supports med-tech. “SINE’s startups have global potential,”
says Pranav Pai.
- Challenges:
Hardware startups like UrjanovaC struggle for funding. “VCs prefer
software for quick returns,” says Vishal. Regulatory hurdles also slow
biotech ventures like ImmunoACT.
Other Incubation Centers
1. IIT Madras Incubation Cell (IITMIC)
IITMIC, established in 2006, is India’s deep-tech leader,
incubating 457 startups valued at ₹50,000 crore. “IITMIC is unmatched in
scale,” says Kris Gopalakrishnan. Achievements include:
- Portfolio:
Unicorns like Ather Energy and Uniphore, 11,000 jobs created, and 250+
patents.
- Funding:
₹12,000 crore raised. “The 80% success rate is a VC’s dream,” says Aditya
Kondawar.
- Comparison:
IITMIC’s valuation dwarfs SINE’s, but SINE’s global outreach via BRICS is
unique.
2. IIT Kanpur Startup Incubation and Innovation Centre
(SIIC)
SIIC, with 300+ startups and a ₹50 crore corpus, excels in
hardware. “We’re the hardware hub,” says Prof. Ankush Sharma. Achievements:
- Portfolio:
Bionic Hope (portable X-rays) and EcoKaari (vegan leather). “Our startups
solve real problems,” says Sharma.
- Funding:
₹15 crore in CSR funds in 2023. “Our corpus is a game-changer,” says Vinod
Keni.
- Comparison:
SIIC’s hardware focus complements SINE’s broader tech scope, but SINE’s
global partnerships are stronger.
3. IIM Bangalore Nadathur S Raghavan Centre for
Entrepreneurial Learning (NSRCEL)
NSRCEL supports 55 startups valued at $1 billion, focusing
on inclusivity. “We empower diverse founders,” says Venkatesh Panchapagesan.
Achievements:
- Portfolio:
Women-led and social ventures like Bellatrix Aerospace. “Inclusivity
drives us,” says Panchapagesan.
- Funding:
Seed grants and MOOCs. “Our model scales entrepreneurs,” says Vinod Dham.
- Comparison:
NSRCEL’s broad focus contrasts with SINE’s deep-tech specialization, but
SINE’s valuation is comparable.
4. T-Hub (Hyderabad)
T-Hub, launched in 2015, supports 2,000+ startups. “We’re a
startup superhighway,” says CEO Mahankali Srinivas Rao. Achievements:
- Portfolio:
Medtronic LABS and Skyroot Aerospace. “We cover all sectors,” says Rao.
- Funding:
₹2,000 crore raised. “Our VC network is robust,” says Pranav Pai.
- Comparison:
T-Hub’s scale rivals SINE’s, but SINE’s deep-tech focus is sharper.
5. Centre for Cellular and Molecular Platforms (C-CAMP,
Bangalore)
C-CAMP, focused on biotech, has incubated 200+ startups.
“We’re biotech pioneers,” says Taslimarif Saiyed. Achievements:
- Portfolio:
Sea6 Energy and Bugworks. “Biotech is our forte,” says Saiyed.
- Funding:
₹500 crore raised. “Our niche attracts specialized VCs,” says Shyam Menon.
- Comparison:
C-CAMP’s biotech focus is narrower than SINE’s, but its patent output is
competitive.
Reflection
SINE’s 21-year journey has cemented its status as a
deep-tech trailblazer, incubating over 200 startups worth $1 billion and
creating 5,500 jobs. “SINE’s model is a playbook for India,” says Shaji
Varghese, and its successes like ImmunoACT’s NexCAR19 prove it. The Centre of
Excellence status and partnerships with DST, Qualcomm, and Canara Bank showcase
its industry clout. Alumni like Nandan Nilekani and corporate backers like
Laurus Labs fuel its ecosystem, as Nilekani notes: “SINE’s alumni network is its
strength.” Yet, hardware startups like UrjanovaC face funding hurdles, as
Vikram Vishal laments: “Hardware needs patient capital.” Regulatory delays,
seen with ImmunoACT, also pose challenges.
The next five years look promising with SINE’s focus on
biotech, climate-tech, and global partnerships. “We’ll double our impact,” says
Poyni Bhatt, and the BRICS collaborations signal global ambitions. Compared to
IITMIC’s massive scale, SIIC’s hardware niche, NSRCEL’s inclusivity, T-Hub’s
volume, and C-CAMP’s biotech focus, SINE strikes a balance of deep-tech and
global outreach. “No single model fits all,” says Bhatt, highlighting India’s
diverse incubation landscape.
SINE’s strength lies in its community—faculty, alumni, and
industry partners. “SINE fosters innovation,” says Bharat Desai, whose funding
birthed the Desai Sethi School. But to lead globally, SINE must address funding
gaps for hardware and streamline regulations. “IP drives valuation,” says
Santosh Gharpure, and SINE’s 200+ IPs position it well. The challenge is
execution—scaling to 100 startups annually while maintaining quality. As
Varghese puts it, “We mentor for long-term impact.” SINE’s blend of innovation,
mentorship, and partnerships could make it a global deep-tech leader, shaping
India’s startup future one breakthrough at a time.
Society for Innovation and Entrepreneurship (SINE) at IIT
Bombay: Achievements Report
Overview
- Established:
2004
- Portfolio:
200+ startups, 55 active, valued at $1 billion
- Jobs
Created: 5,500
- Intellectual
Property: 200+ IPs, including 41 from IIT Bombay
- Funding
Raised: $736.91 million, with $3.92 million in seed funding from SINE
Key Achievements
- Notable
Startups:
- ImmunoACT:
Launched NexCAR19, India’s first CAR-T cell therapy for cancer (2025).
- IdeaForge:
Drone tech leader, raised $20 million.
- Detect
Technologies: AI-based industrial monitoring.
- UrjanovaC:
CO2 capture technology for net-zero emissions.
- Voltrez
Tech: Safe lithium-ion batteries.
- Industry
Partnerships: Collaborations with DST, Qualcomm, Intel, and Canara
Bank.
- Global
Recognition: Centre of Excellence by DST, BRICS partnerships.
- Events:
E-Summit (Asia’s largest business conclave), IPR workshops.
Future Outlook
- Goal:
Incubate 100 startups annually by 2030.
- Focus
Areas: Biotech, climate-tech, AI.
- Global
Expansion: Strengthen BRICS and international ties.
- IP
Target: 300 IPs by 2028.
Challenges
- Funding:
Hardware startups struggle for VC investment.
- Regulations:
Biotech ventures face delays.
Investor Highlights
- Alumni:
Nandan Nilekani, Bhavish Aggarwal, Bharat Desai.
- Corporate
VCs: Laurus Labs, Qualcomm, Intel, Canara Bank.
- VC
Firms: Florintree, Blume Ventures, 3one4 Capital.
References
1. “SINE
IIT Bombay: Annual Report 2024,” SINE Website.
2. “ImmunoACT’s
NexCAR19 Launch,” India Science and Technology, 2025.
3. “IIT
Bombay Entrepreneurial Ecosystem,” IIT Bombay Website, 2023.
4. “SINE’s
Playbook for Incubation,” Indian Express, 2024.
5. “IdeaForge’s
Drone Tech Success,” Business Standard, 2024.
6. “Voltrez
Tech Battery Innovation,” SINE Blog, 2024.
7. “UrjanovaC’s
CO2 Capture,” SINE Website, 2023.
8. X
Post by @SINEIITB, “Project Titanium,” May 2025.
9. Interview
with Shaji Varghese, “SINE’s Impact,” Indian Express, 2024.
10. “E-Summit
2025,” E-Cell IIT Bombay, 2024
Comments
Post a Comment